Antiparkinsonian drugs memantine and trihexyphenidyl potentiate the anticonvulsant activity of valproate against maximal electroshock-induced seizures.
about
Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases.Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments?Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction.N-methyl-D-aspartate receptor channel blockers prevent pentylenetetrazole-induced convulsions and morphological changes in rat brain neurons.Competitive NMDA-receptor antagonists, LY 235959 and LY 233053, enhance the protective efficacy of various antiepileptic drugs against maximal electroshock-induced seizures in mice.
P2860
Antiparkinsonian drugs memantine and trihexyphenidyl potentiate the anticonvulsant activity of valproate against maximal electroshock-induced seizures.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Antiparkinsonian drugs memanti ...... electroshock-induced seizures.
@en
Antiparkinsonian drugs memanti ...... electroshock-induced seizures.
@nl
type
label
Antiparkinsonian drugs memanti ...... electroshock-induced seizures.
@en
Antiparkinsonian drugs memanti ...... electroshock-induced seizures.
@nl
prefLabel
Antiparkinsonian drugs memanti ...... electroshock-induced seizures.
@en
Antiparkinsonian drugs memanti ...... electroshock-induced seizures.
@nl
P2093
P1433
P1476
Antiparkinsonian drugs memanti ...... electroshock-induced seizures.
@en
P2093
P304
P356
10.1016/0028-3908(92)90103-V
P577
1992-10-01T00:00:00Z